155 related articles for article (PubMed ID: 37846176)
1. Resection of positive tissue on methionine-PET is associated with improved survival in glioblastomas.
Ohmura K; Daimon T; Ikegame Y; Yano H; Yokoyama K; Kumagai M; Shinoda J; Iwama T
Brain Behav; 2023 Dec; 13(12):e3291. PubMed ID: 37846176
[TBL] [Abstract][Full Text] [Related]
2. Met-PET uptake index for total tumor resection: identification of
Inoue A; Ohnishi T; Kohno S; Ohue S; Nishikawa M; Suehiro S; Matsumoto S; Ozaki S; Fukushima M; Kurata M; Kitazawa R; Shigekawa S; Watanabe H; Kunieda T
Neurosurg Rev; 2021 Feb; 44(1):587-597. PubMed ID: 32060762
[TBL] [Abstract][Full Text] [Related]
3. [11C] methionine and [18F] fluorodeoxyglucose PET in the follow-up of glioblastoma multiforme.
Pötzi C; Becherer A; Marosi C; Karanikas G; Szabo M; Dudczak R; Kletter K; Asenbaum S
J Neurooncol; 2007 Sep; 84(3):305-14. PubMed ID: 17492401
[TBL] [Abstract][Full Text] [Related]
4. Metabolic delineation of IDH1 wild-type glioblastoma surgical anatomy: how to plan the tumor extent of resection.
Altieri R; Certo F; Pacella D; Cammarata G; Garozzo M; Broggi G; Caltabiano R; Magro G; Russo G; Cosentino S; Ippolito M; Barbagallo G
J Neurooncol; 2023 Apr; 162(2):417-423. PubMed ID: 37039952
[TBL] [Abstract][Full Text] [Related]
5. Volumetric Analysis Using Low-Field Intraoperative Magnetic Resonance Imaging for 168 Newly Diagnosed Supratentorial Glioblastomas: Effects of Extent of Resection and Residual Tumor Volume on Survival and Recurrence.
Fukui A; Muragaki Y; Saito T; Maruyama T; Nitta M; Ikuta S; Kawamata T
World Neurosurg; 2017 Feb; 98():73-80. PubMed ID: 27989974
[TBL] [Abstract][Full Text] [Related]
6. Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.
Grabowski MM; Recinos PF; Nowacki AS; Schroeder JL; Angelov L; Barnett GH; Vogelbaum MA
J Neurosurg; 2014 Nov; 121(5):1115-23. PubMed ID: 25192475
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of intraoperative perfusion-weighted MRI and 5-aminolevulinic acid in relation to contrast-enhanced intraoperative MRI and
Pala A; Reske SN; Eberhardt N; Scheuerle A; König R; Schmitz B; Beer AJ; Wirtz CR; Coburger J
Neurosurg Rev; 2019 Jun; 42(2):471-479. PubMed ID: 29808321
[TBL] [Abstract][Full Text] [Related]
8. Role of amide proton transfer imaging in maximizing tumor resection in malignant glioma: a possibility to take the place of
Inoue A; Watanabe H; Kusakabe K; Nishikawa M; Shiraishi Y; Taniwaki M; Takimoto Y; Harada M; Furumochi T; Shigekawa S; Kitazawa R; Kido T; Ohnishi T; Kunieda T
Neurosurg Rev; 2023 Nov; 46(1):294. PubMed ID: 37925381
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of
Norikane T; Mitamura K; Yamamoto Y; Manabe Y; Murao M; Arai-Okuda H; Hatakeyama T; Miyake K; Nishiyama Y
J Neurooncol; 2024 Jan; 166(1):195-201. PubMed ID: 38160415
[TBL] [Abstract][Full Text] [Related]
10. Radiomics for residual tumour detection and prognosis in newly diagnosed glioblastoma based on postoperative [
Shahzadi I; Seidlitz A; Beuthien-Baumann B; Zwanenburg A; Platzek I; Kotzerke J; Baumann M; Krause M; Troost EGC; Löck S
Sci Rep; 2024 Feb; 14(1):4576. PubMed ID: 38403632
[TBL] [Abstract][Full Text] [Related]
11. Which Parameter Is More Important for the Prognosis of New-Onset Adult Glioblastoma: Residual Tumor Volume or Extent of Resection?
Xing Y; Wang X
World Neurosurg; 2018 Aug; 116():e444-e451. PubMed ID: 29753893
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of postoperative, pre-irradiation (18)F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy.
Piroth MD; Holy R; Pinkawa M; Stoffels G; Kaiser HJ; Galldiks N; Herzog H; Coenen HH; Eble MJ; Langen KJ
Radiother Oncol; 2011 May; 99(2):218-24. PubMed ID: 21497925
[TBL] [Abstract][Full Text] [Related]
13. Impact of [11C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning.
Matsuo M; Miwa K; Tanaka O; Shinoda J; Nishibori H; Tsuge Y; Yano H; Iwama T; Hayashi S; Hoshi H; Yamada J; Kanematsu M; Aoyama H
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):83-9. PubMed ID: 21095072
[TBL] [Abstract][Full Text] [Related]
14. Oncological and functional outcomes of supratotal resection of IDH1 wild-type glioblastoma based on
Hirono S; Ozaki K; Kobayashi M; Hara A; Yamaki T; Matsutani T; Iwadate Y
Sci Rep; 2021 Jul; 11(1):14554. PubMed ID: 34267303
[TBL] [Abstract][Full Text] [Related]
15. C11 Methionine PET (MET-PET) Imaging of Glioblastoma for Detecting Postoperative Residual Disease and Response to Chemoradiation Therapy.
Wang Y; Rapalino O; Heidari P; Loeffler J; Shih HA; Oh K; Mahmood U
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1024-1028. PubMed ID: 29913253
[TBL] [Abstract][Full Text] [Related]
16. Impact of removed tumor volume and location on patient outcome in glioblastoma.
Awad AW; Karsy M; Sanai N; Spetzler R; Zhang Y; Xu Y; Mahan MA
J Neurooncol; 2017 Oct; 135(1):161-171. PubMed ID: 28685405
[TBL] [Abstract][Full Text] [Related]
17. When gross total resection of a glioblastoma is possible, how much resection should be achieved?
Chaichana KL; Cabrera-Aldana EE; Jusue-Torres I; Wijesekera O; Olivi A; Rahman M; Quinones-Hinojosa A
World Neurosurg; 2014; 82(1-2):e257-65. PubMed ID: 24508595
[TBL] [Abstract][Full Text] [Related]
18. l-[METHYL-(11)C] methionine positron emission tomography for target delineation in malignant gliomas: impact on results of carbon ion radiotherapy.
Mahasittiwat P; Mizoe JE; Hasegawa A; Ishikawa H; Yoshikawa K; Mizuno H; Yanagi T; Takagi R; Pattaranutaporn P; Tsujii H
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):515-22. PubMed ID: 17900820
[TBL] [Abstract][Full Text] [Related]
19. A surgical strategy using a fusion image constructed from 11C-methionine PET, 18F-FDG-PET and MRI for glioma with no or minimum contrast enhancement.
Ideguchi M; Nishizaki T; Ikeda N; Okamura T; Tanaka Y; Fujii N; Ohno M; Shimabukuro T; Kimura T; Ikeda E; Suga K
J Neurooncol; 2018 Jul; 138(3):537-548. PubMed ID: 29516344
[TBL] [Abstract][Full Text] [Related]
20. Determining a cut-off residual tumor volume threshold for patients with newly diagnosed glioblastoma treated with temozolomide chemoradiotherapy: A multicenter cohort study.
Woo PYM; Ho JMK; Tse TPK; Lam SW; Mak CHK; Chan DTM; Lee MWY; Wong ST; Chan KY; Poon WS
J Clin Neurosci; 2019 May; 63():134-141. PubMed ID: 30712777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
